Right now, the larger deliverable in motion is Iran. The Hormuz and nuclear-file negotiations running in parallel to the Gaza ...
On August 4, the Democratic Party of Korea described the government's proposed tax law revision for next year as a "tax ...
People who test positive for type 1 diabetes autoantibodies and have overweight or obesity may lower their risk for stage 3 ...
Options Technology has extended AtlasFeed to the Texas Stock Exchange, new US options depth feeds and Abu Dhabi, Dubai and Borsa Istanbul connectivity.
July fighting squashed the promise of a June ceasefire and the Strait of Hormuz reopening, along with packaging converters’ ...
Healthcare leaders must quantify direct gains from a tool, and if it's not delivering, figure out why and fix it.
FDA acceptance of the new drug application for lonafarnib marks a key milestone toward an oral treatment option for chronic hepatitis D.
Denali Therapeutics (DNLI) is transitioning from a neuroscience platform to a commercial biotech with AVLAYAH, its FDA-approved rare-disease therapy. AVLAYAH's Q2 revenue of $3.6M is projected to ...
Patrick Söderlund (Chairman), Lee Jung-hun (CEO), Shiro Uemura (CFO) Agenda: Nexon Q2 2026 Earnings and Future Strategy (以上引用 ...
Q2 2026 earnings call recap: record $41.9M revenue, EBITDA growth, expansion timelines, and risks amid price compression—read now.
Detailed price information for Exxonmobil Holdings Corp (XOM-N) from The Globe and Mail including charting and trades.
PRNewswire/ -- n6, maker of the icon96™ and icon16 thermocyclers powered by iconPCR™ with AutoNorm intelligent normalization technology for next-generation sequencing (NGS) library preparation, today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results